Preview Mode Links will not work in preview mode

HR Benecast

Learn about new trends, developments, changes and other topics of interest in the employee benefits world from Employers Health’s Chief Strategy Officer, Mike Stull. During our monthly podcasts we’ll answer your most frequently asked human resources and employee benefits questions. 

Mar 27, 2025

Biosimilars have been around for nearly a decade, but with Humira's list price of around $7,000, biosimilars for the drug are making an incredible splash in the pharmacy industry. With several biosimilars already launched in 2025 and more in the pipeline, many plan sponsors are wondering how to navigate the integration...


Jan 27, 2025

Our host, Mike Stull, talks with Employers Health's Senior Vice President, Regulatory Compliance and External Affairs Madison Connor as she covers the latest state and federal employee benefits and PBM legislation under the new presidential administration. Together, they'll cover proposed bills affecting anti-steering...


Dec 12, 2024

Cell and gene therapies (CGT) are widely considered a triumph of scientific innovation, focusing on providing cures for diseases rather than treatments. By 2030, it’s predicted that over 100,000 U.S. patients will utilize some form of CGT. While CGTs are revolutionary, these therapies come with a giant price tag,...


Aug 27, 2024

In this episode of HR Benecast, Mike Stull and Eric Dublikar cover your pharmacy and employee benefits questions including:  

  • What's new in federal and state pharmacy benefit legislation.
  • How Employers Health is working to help clients manage changes to their PBM plans. 
  • What the switch to biosimilars for Humira and...


Jul 1, 2024

This episode features Employers Health Chief Operating Officer, Zach Hostetler. He joins our Chief Sales Officer, Mike Stull to discuss pharmacy benefit rebate credits and why they exist. They'll cover how rebate credits are calculated, how long we can expect rebate credits to be around, how Employers Health is working...